Selectively Targeting T- and B-Cell Lymphomas: A Benzothiazole Antagonist of α(4)β(1) Integrin

Current cancer chemotherapeutic agents clinically deployed today are designed to be indiscriminately cytotoxic, however achieving selective targeting of cancer malignancies would allow for improved diagnostic and chemotherapeutic tools. Integrin α(4)β(1), a heterodimeric cell surface receptor, is be...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Carpenter, Richard D., Andrei, Mirela, Aina, Olulanu H., Lau, Edmond Y., Lightstone, Felice C., Liu, Ruiwu, Lam, Kit S., Kurth, Mark J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3164867/
https://ncbi.nlm.nih.gov/pubmed/19072684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm800313f
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky